These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31266624)

  • 1. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies.
    Sasadeusz J; Grigg A; Hughes PD; Lim SL; Lucas M; McColl G; McLachlan SA; Peters MG; Shackel N; Slavin M; Sundararajan V; Thompson A; Doyle J; Rickard J; De Cruz P; Gish RG; Visvanathan K
    Clin Liver Dis; 2019 Aug; 23(3):511-519. PubMed ID: 31266624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis.
    Paul S; Dickstein A; Saxena A; Terrin N; Viveiros K; Balk EM; Wong JB
    Hepatology; 2017 Aug; 66(2):379-388. PubMed ID: 28128861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
    Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
    World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.
    Zhang MY; Zhu GQ; Zheng JN; Cheng Z; Van Poucke S; Shi KQ; Huang HH; Chen FY; Zheng MH
    Expert Rev Anti Infect Ther; 2017 May; 15(5):503-513. PubMed ID: 28317397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology.
    Sasadeusz J; Grigg A; Hughes PD; Lee Lim S; Lucas M; McColl G; McLachlan SA; Peters MG; Shackel N; Slavin M; Sundararajan V; Thompson A; Doyle J; Rickard J; De Cruz P; Gish RG; Visvanathan K
    Clin Liver Dis; 2019 Aug; 23(3):487-492. PubMed ID: 31266622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents.
    Sasadeusz J; Grigg A; Hughes PD; Lee Lim S; Lucas M; McColl G; McLachlan SA; Peters MG; Shackel N; Slavin M; Sundararajan V; Thompson A; Doyle J; Rickard J; De Cruz P; Gish RG; Visvanathan K
    Clin Liver Dis; 2019 Aug; 23(3):521-534. PubMed ID: 31266625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.
    Chen CY; Tien FM; Cheng A; Huang SY; Chou WC; Yao M; Tang JL; Tien HF; Sheng WH
    BMC Gastroenterol; 2018 Jan; 18(1):6. PubMed ID: 29310589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Hepatitis B Reactivation Among Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.
    Atteya A; Ahmad A; Daghstani D; Mushtaq K; Yassin MA
    Cancer Control; 2020; 27(1):1073274820976594. PubMed ID: 33297765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
    Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
    J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
    Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus reactivation associated with anti-neoplastic therapy.
    Yeo W; Chan HL
    J Gastroenterol Hepatol; 2013 Jan; 28(1):31-7. PubMed ID: 23020594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.
    Lalazar G; Rund D; Shouval D
    Br J Haematol; 2007 Mar; 136(5):699-712. PubMed ID: 17338776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
    Hwang JP; Suarez-Almazor ME; Cantor SB; Barbo A; Lin HY; Ahmed S; Chavez-MacGregor M; Donato-Santana C; Eng C; Ferrajoli A; Fisch MJ; McLaughlin P; Simon GR; Rondon G; Shpall EJ; Lok AS
    Cancer; 2017 Sep; 123(17):3367-3376. PubMed ID: 28518219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients.
    Sasadeusz J; Grigg A; Hughes PD; Lee Lim S; Lucas M; McColl G; McLachlan SA; Peters MG; Shackel N; Slavin M; Sundararajan V; Thompson A; Doyle J; Rickard J; De Cruz P; Gish RG; Visvanathan K
    Clin Liver Dis; 2019 Aug; 23(3):493-509. PubMed ID: 31266623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy.
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Tachi Y; Ishikawa T; Katano Y; Yoshioka K; Toyoda H; Kumada T; Goto H; Hirooka Y
    J Gastroenterol; 2016 Nov; 51(11):1081-1089. PubMed ID: 26943169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of hepatitis B virus infection in patients with hematologic disorders.
    Wang B; Mufti G; Agarwal K
    Haematologica; 2019 Mar; 104(3):435-443. PubMed ID: 30733266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of hepatitis B virus reactivation in patients with hematological malignancies.
    Pompili M; Basso M; Hohaus S; Bosco G; Nosotti L; D'Andrea M; Fenu S; Grieco A; Laurenti L; Mirisola C; Pagano L; Rapaccini GL; Sica S; Storti S; Landolfi R
    Ann Hepatol; 2015; 14(2):168-74. PubMed ID: 25671825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and Prevention of Hepatitis B Virus Reactivation During Chemotherapy.
    Ludwig E; Cohen N; Papanicolaou GA; Seo SK
    Oncology (Williston Park); 2015 Dec; 29(12):937, 940, 943. PubMed ID: 26676897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.